Akebia Therapeutics Inc Revenue per Employee (AKBA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Akebia Therapeutics Inc   (NASDAQ: AKBA)
 

Akebia Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Akebia Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,129,175, but the productivity of Akebia Therapeutics Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 67 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 740, from total ranking in previous quarter at 898. Akebia Therapeutics Inc has 194 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AKBA Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change -21.36 % -6.61 % 23.93 % 57.01 % 43.13 %
Sales per Employee (TTM) $ 1,129,175 1,197,959 1,217,505 1,160,160 1,050,170
AKBA's Total Ranking # 740 # 898 # 776 # 831 # 915
Seq. Revenue Change -8.25 % -7.08 % -1.95 % -5.93 % 8.96 %

AKBA Company Profile >> Back to AKBA Efficiency Comparisons >> Compare AKBA Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 45
Healthcare Sector # 68
Overall Market # 740

Revenue per Employee Statistics
High Average Low
$ 1,808,314 $ 1,066,697 $ 0
(Mar 31 2020)   (Dec 31 2015)



Financial Statements
Akebia Therapeutics Inc 's Revenue MRQ $ 49 Millions Visit AKBA's Income Statement
Akebia Therapeutics Inc 's Revenues TTM $ 219 Millions Visit AKBA's aggregate revenue growth
What are AKBA's Sales? Visit AKBA's Sales by Segment




Other Ratios
Akebia Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
AKBA's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for AKBA's Competitors
Revenue per Employee for AKBA's Suppliers
Revenue per Employee for AKBA's Customers

You may also want to know
AKBA's Sales Growth Rates AKBA's Pe Price to earnings ratio AKBA's Receivables Turnover Ratio AKBA's Stock Quote
AKBA's Net Income Growth Rates AKBA's Ps Price to Sales ratio AKBA's Sales per Employee AKBA's Asset Turnover Ratio
AKBA's Net Margin AKBA's Pb Price to Book ratio AKBA's Financial Strength Ratios AKBA's Dividend Payout Ratio
Date modified: 2026-09-09T01:58:45+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Prestige Consumer Healthcare Inc   1,938,521.05 $ 1,104.957  Million 570 
Privia Health Group Inc   1,923,384.18 $ 2,358.069  Million 1,226 
Alnylam Pharmaceuticals Inc   1,921,672.80 $ 4,804.182  Million 2,500 
Gilead Sciences Inc   1,791,588.24 $ 30,457.000  Million 17,000 
Collegium Pharmaceutical Inc   1,777,172.58 $ 751.744  Million 423 
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 
Mirum Pharmaceuticals Inc   1,661,470.43 $ 618.067  Million 372 
Tarsus Pharmaceuticals Inc   1,638,732.43 $ 606.331  Million 370 
Agenus Inc  1,638,185.19 $ 132.693  Million 81 
Xenetic Biosciences Inc   1,630,388.50 $ 3.261  Million 2 
Ideaya Biosciences Inc   1,614,668.97 $ 234.127  Million 145 
Eli Lilly And Company  1,593,316.00 $ 79,665.800  Million 50,000 
Jazz Pharmaceuticals Plc  1,592,122.15 $ 4,601.233  Million 2,890 
Rigel Pharmaceuticals Inc  1,590,718.39 $ 276.785  Million 174 
Progyny Inc   1,531,890.19 $ 1,311.298  Million 856 
Bristol myers Squibb Company  1,513,415.38 $ 49,186.000  Million 32,500 
Krystal Biotech Inc   1,493,166.10 $ 440.484  Million 295 
Acadia Pharmaceuticals Inc   1,426,870.93 $ 1,138.643  Million 798 
Madrigal Pharmaceuticals Inc   1,403,213.11 $ 1,283.940  Million 915 
Indivior Pharmaceuticals Inc   1,333,000.00 $ 1,333.000  Million 1,000 
Arcutis Biotherapeutics Inc   1,310,680.79 $ 463.981  Million 354 
Lantheus Holdings Inc   1,303,724.22 $ 1,555.343  Million 1,193 
Cue Biopharma Inc   1,298,413.79 $ 37.654  Million 29 
Puma Biotechnology Inc   1,291,865.92 $ 231.244  Million 179 
Arvinas Inc   1,287,398.37 $ 316.700  Million 246 
Supernus Pharmaceuticals inc   1,273,677.91 $ 830.438  Million 652 
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 
Journey Medical Corp  1,175,534.48 $ 68.181  Million 58 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.